Abstract

The aetiology of Amyotrophic Lateral Sclerosis (ALS) is still poorly understood. The discovery of genetic forms of ALS pointed out the mechanisms underlying this pathology, but also showed how complex these mechanisms are. Excitotoxicity is strongly suspected to play a role in ALS pathogenesis. Excitotoxicity is defined as neuron damage due to excessive intake of calcium ions (Ca2+) by the cell. This study aims to find a relationship between the proteins coded by the most relevant genes associated with ALS and intracellular Ca2+ accumulation. In detail, the profile of eight proteins (TDP-43, C9orf72, p62/sequestosome-1, matrin-3, VCP, FUS, SOD1 and profilin-1), was analysed in three different cell types induced to raise their cytoplasmic amount of Ca2+. Intracellular Ca2+ accumulation causes a decrease in the levels of TDP-43, C9orf72, matrin3, VCP, FUS, SOD1 and profilin-1 and an increase in those of p62/sequestosome-1. These events are associated with the proteolytic action of two proteases, calpains and caspases, as well as with the activation of autophagy. Interestingly, Ca2+ appears to both favour and hinder autophagy. Understanding how and why calpain-mediated proteolysis and autophagy, which are physiological processes, become pathological may elucidate the mechanisms responsible for ALS and help discover new therapeutic targets.

Details

Title
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis
Author
De, Marco Giovanni 1   VIAFID ORCID Logo  ; Lomartire Annarosa 2 ; Manera Umberto 2 ; Canosa, Antonio 1 ; Grassano Maurizio 2 ; Casale Federico 2 ; Fuda Giuseppe 2 ; Salamone Paolina 1 ; Rinaudo, Maria Teresa 3 ; Colombatto Sebastiano 3 ; Moglia, Cristina 1 ; Chiò Adriano 4 ; Calvo, Andrea 5 

 University of Turin, Department of Neuroscience, ALS Centre, “Rita Levi Montalcini”, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Neurology Unit 1, Turin, Italy (GRID:grid.432329.d) (ISNI:0000 0004 1789 4477) 
 University of Turin, Department of Neuroscience, ALS Centre, “Rita Levi Montalcini”, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
 University of Turin, Department of Oncology, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
 University of Turin, Department of Neuroscience, ALS Centre, “Rita Levi Montalcini”, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Neurology Unit 1, Turin, Italy (GRID:grid.432329.d) (ISNI:0000 0004 1789 4477); Neuroscience Institute of Turin (NIT), Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); Institute of Cognitive Sciences and Technologies, C.N.R., Rome, Italy (GRID:grid.428479.4) (ISNI:0000 0001 2297 9633) 
 University of Turin, Department of Neuroscience, ALS Centre, “Rita Levi Montalcini”, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Neurology Unit 1, Turin, Italy (GRID:grid.432329.d) (ISNI:0000 0004 1789 4477); Neuroscience Institute of Turin (NIT), Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2618381683
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.